Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -11.10%32.22M | -33.97%84.59M | -41.24%36.25M | 33.35%128.11M | 36.95%99.49M | 51.90%61.68M | 32.99%28.15M | -28.94%96.07M | -29.03%72.64M | -38.38%40.61M |
| Operating income | -11.10%32.22M | -33.97%84.59M | -41.24%36.25M | 33.35%128.11M | 36.95%99.49M | 51.90%61.68M | 32.99%28.15M | -28.94%96.07M | -29.03%72.64M | -38.38%40.61M |
| Cost of sales | 22.63%-13.68M | 25.87%-44.94M | 39.84%-17.68M | -37.19%-60.62M | -50.43%-49.18M | -64.91%-29.39M | -34.90%-12.72M | 29.03%-44.19M | 31.40%-32.69M | 41.99%-17.82M |
| Operating expenses | 22.63%-13.68M | 25.87%-44.94M | 39.84%-17.68M | -37.19%-60.62M | -50.43%-49.18M | -64.91%-29.39M | -34.90%-12.72M | 29.03%-44.19M | 31.40%-32.69M | 41.99%-17.82M |
| Gross profit | -0.13%18.54M | -41.25%39.65M | -42.51%18.56M | 30.08%67.49M | 25.93%50.31M | 41.73%32.29M | 31.46%15.43M | -28.86%51.88M | -26.97%39.95M | -35.23%22.78M |
| Selling expenses | 14.92%-16.25M | 32.27%-40.39M | 36.52%-19.1M | -13.43%-59.64M | -18.58%-47.16M | -25.77%-30.08M | -11.50%-14.23M | 26.40%-52.58M | 25.01%-39.77M | 29.00%-23.92M |
| Administrative expenses | 19.26%-5.01M | 2.48%-13.23M | 13.88%-6.2M | 21.94%-13.56M | 15.33%-9.99M | 10.80%-7.2M | 3.67%-3.28M | -1.30%-17.37M | -11.44%-11.8M | -13.48%-8.08M |
| Impairment and provision | ---- | -190.24%-758K | ---- | 165.27%840K | 128.13%405K | 128.13%405K | ---- | -389.21%-1.29M | 11.87%-1.44M | 11.87%-1.44M |
| -Impairment of intangible assets | ---- | ---852K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | -88.81%94K | ---- | 165.27%840K | 128.13%405K | 128.13%405K | ---- | -389.21%-1.29M | 11.87%-1.44M | 11.87%-1.44M |
| Special items of operating profit | 142.58%3.53M | 662.08%5.65M | -17.13%1.46M | -72.24%741K | 124.19%4.84M | 74.83%1.76M | 60.31%1.47M | -42.07%2.67M | -50.81%2.16M | -69.39%1.01M |
| Operating profit | 115.50%818K | -119.73%-9.08M | -86.44%-5.28M | 75.25%-4.13M | 85.35%-1.6M | 70.64%-2.83M | 82.58%-612K | -57.37%-16.69M | -76.67%-10.9M | -142.56%-9.64M |
| Financing cost | -0.54%-749K | -3.59%-1.47M | -59.87%-745K | -117.10%-1.42M | -84.50%-762K | -94.17%-466K | -86.24%-203K | -50.57%-655K | -34.09%-413K | -22.45%-240K |
| Earning before tax | 101.15%69K | -89.99%-10.55M | -82.68%-6.02M | 67.98%-5.55M | 79.15%-2.36M | 66.64%-3.3M | 77.50%-815K | -57.11%-17.34M | -74.65%-11.31M | -136.91%-9.88M |
| Tax | ---- | 91.84%-139K | ---- | -910.95%-1.7M | ---- | ---- | ---- | -77.37%210K | ---- | ---- |
| After-tax profit from continuing operations | 101.15%69K | -47.31%-10.69M | -82.68%-6.02M | 57.65%-7.26M | 79.15%-2.36M | 66.64%-3.3M | 77.50%-815K | -69.45%-17.13M | -74.43%-11.31M | -136.46%-9.88M |
| After-tax profit from non-continuing business | ---- | ---- | ---891K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | 101.00%69K | -47.31%-10.69M | -109.71%-6.91M | 57.65%-7.26M | 79.15%-2.36M | 66.64%-3.3M | 77.50%-815K | -69.45%-17.13M | -74.43%-11.31M | -136.46%-9.88M |
| Minority shareholders should account for non-continuing business profits | ---- | ---- | ---684K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Minority profit | ---- | -168.08%-676K | -670.00%-684K | 218.64%993K | 197.44%647K | 114.91%120K | 145.83%154K | 44.68%-837K | 38.18%-664K | 7.79%-805K |
| Shareholders should account for profits from continuing business | 101.15%69K | ---- | ---6.02M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---207K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 101.11%69K | -21.38%-10.01M | -82.32%-6.23M | 49.38%-8.25M | 71.77%-3.01M | 62.36%-3.42M | 70.52%-969K | -89.53%-16.3M | -96.78%-10.65M | -174.54%-9.08M |
| Basic earnings per share | 100.90%0.0001 | -21.77%-0.0179 | -81.97%-0.0111 | 49.48%-0.0147 | 71.58%-0.0054 | 62.35%-0.0061 | 71.19%-0.0017 | -88.96%-0.0291 | -95.88%-0.019 | -174.58%-0.0162 |
| Diluted earnings per share | 100.90%0.0001 | -21.77%-0.0179 | -81.97%-0.0111 | 49.48%-0.0147 | 71.58%-0.0054 | 62.35%-0.0061 | 71.19%-0.0017 | -88.96%-0.0291 | -95.88%-0.019 | -174.58%-0.0162 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | -- | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.